To find out more about AMP’s recommendations for defining clinical utility as it applies to molecular diagnostics, CLP recently spoke with Elaine Lyon, PhD, medical director of genetics, genomics, and pharmacogenomics at ARUP Laboratories.
Read More
The simple blood test identifies individuals who are at risk of experiencing a heart attack, and for whom early intervention can help.
Read More
A molecular diagnostic from Luminex is the latest to receive emergency use authorization to detect Zika virus.
Read More
A novel statistical approach has facilitated the classification of variants in high- and moderate-risk genes.
Read More
Improvements in liquid biopsy techniques are offering a more holistic view of cancer.
Read More